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INTRODUCTION
Many neural and non-neural cell types in vertebrates are produced
by the neural crest, a transient embryonic structure that emerges
during neurulation in the dorsal part of the neural tube (Le Douarin
et al., 2008). Among the neural crest derivatives are the pigment
cells in the skin that are reported to originate either directly from
neural crest cells migrating from the neural tube on a dorsolateral
pathway or from nerves innervating the skin (Sommer, 2011).
Melanocyte lineage specification of dorsolaterally migrating cells
is thought to occur at an early stage of neural crest development.
Cells fated for the melanocyte lineage stall in the migration staging
area (MSA) adjacent to the neural tube before continuing their
dorsolateral migration (Weston, 1991). In the MSA, melanocyte
specification is indicated by expression of the microphthalmia-
associated transcription factor (Mitf), which controls melanoblast
development and survival (Opdecamp et al., 1997). Both in cell
culture and in vivo, expression of Mitf is regulated by canonical
Wnt signaling, indicating a central role of this signal transduction
pathway in melanocyte development (Dorsky et al., 2000; Takeda
et al., 2000; Hari et al., 2002; Widlund et al., 2002).
Canonical Wnt signaling involves the intracellular signaling
component -catenin, which, upon activation, translocates to the
nucleus and induces specific transcriptional responses (Gordon and
Nusse, 2006). In cultures of mouse and quail neural crest cells,
treatment with Wnt or activation of -catenin enhances melanoblast
proliferation and differentiation (Dunn et al., 2000; Jin et al., 2001).
More strikingly, constitutive activation of -catenin in zebrafish in
vivo promotes the formation of melanocytes while repressing neural
cell lineages (Dorsky et al., 1998). By contrast, upon inhibition of
Wnt signaling, neural crest cells adopt a neural rather than a pigment
cell fate. Similarly, in the mouse, conditional deletion of -catenin
(Ctnnb1) in premigratory neural crest cells also prevents the
generation of melanocytes (Hari et al., 2002). However, unlike in
zebrafish, inactivation of Ctnnb1 in the mouse neural crest not only
prevents melanocyte formation but also sensory neurogenesis (Hari
et al., 2002). Moreover, in contrast to zebrafish, Ctnnb1 signal
activation in the mouse neural crest in vivo does not enhance
melanocyte formation, but rather promotes the widespread formation
of sensory neurons at the expense of virtually all other possible
neural crest cell fates, including melanocytes (Lee et al., 2004).
In the present study we offer an explanation for these
inconsistent findings, suggesting that in mouse embryos Wnt/-
catenin signaling controls sensory fate acquisition before regulating
melanocyte lineage formation. To analyze the temporal control of
neural crest lineage generation by Wnt/-catenin signaling, we
genetically manipulated Ctnnb1 at different stages of neural crest
and early melanocyte development. Our results are in agreement
with the idea that sensory neuronal and melanocyte lineages are
successively generated from neural crest cells by sequential -
catenin signaling.
MATERIALS AND METHODS
Animals and genotyping
The Cre-loxP system was used to conditionally express a stabilized form
of -catenin as described (Lee et al., 2004). Mutant embryos were
heterozygous for Cre and for Ctnnb1ex3. Littermates inheriting an
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SUMMARY
Wnt/-catenin signaling controls multiple steps of neural crest development, ranging from neural crest induction, lineage
decisions, to differentiation. In mice, conditional -catenin inactivation in premigratory neural crest cells abolishes both sensory
neuron and melanocyte formation. Intriguingly, the generation of melanocytes is also prevented by activation of -catenin in the
premigratory neural crest, which promotes sensory neurogenesis at the expense of other neural crest derivatives. This raises the
question of how Wnt/-catenin signaling regulates the formation of distinct lineages from the neural crest. Using various Cre
lines to conditionally activate -catenin in neural crest cells at different developmental stages, we show that neural crest cell fate
decisions in vivo are subject to temporal control by Wnt/-catenin. Unlike in premigratory neural crest, -catenin activation in
migratory neural crest cells promotes the formation of ectopic melanoblasts, while the production of most other lineages is
suppressed. Ectopic melanoblasts emerge at sites of neural crest target structures and in many tissues usually devoid of neural
crest-derived cells. -catenin activation at later stages in glial progenitors or in melanoblasts does not lead to surplus
melanoblasts, indicating a narrow time window of Wnt/-catenin responsiveness during neural crest cell migration. Thus, neural
crest cells appear to be multipotent in vivo both before and after emigration from the neural tube but adapt their response to
extracellular signals in a temporally controlled manner.
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incomplete combination of alleles, i.e. either Cre or Ctnnb1ex3, served as
controls. For in vivo fate mapping experiments, either ROSA26 reporter
(R26R) (Soriano, 1999) or Z/EG (Novak et al., 2000) mouse lines were
used. Embryos carrying one allele for lineage tracing are indicated as R26R
or Z/EG. The following Cre lines were used: Wnt1-Cre (Danielian et al.,
1998), Sox10-Cre (Matsuoka et al., 2005), Dhh-Cre (Jaegle et al., 2003;
Joseph et al., 2004), Plp-CreERT2 (Leone et al., 2003) and Tyr-CreERT2
(Bosenberg et al., 2006). Genotyping for all Cre alleles was performed by
PCR with primers Cre-up (5-ACCAGGTTCGTTCACTCATGG-3) and
Cre-lo (5-AGGCTAAGTGCCTTCTCTACAC-3) and 35 cycles of 94°C
for 45 seconds, 58°C for 30 seconds and 72°C for 1 minute, to amplify a
217 bp fragment within the Cre ORF.
Inducible Cre expression
For activation of the CreERT2 protein, tamoxifen (Sigma T5648) was
dissolved in 1:10 ethanol:sunflower oil at 10 mg/ml. Tamoxifen (1 mg) was
injected intraperitoneally into the pregnant mother on 1 day for Plp-
CreERT2 mice at the indicated stages and on 2 consecutive days at E11.5
and E12.5 for Tyr-CreERT2 mice.
In situ hybridization, X-Gal staining and immunohistochemistry
In situ hybridization on cryosections with digoxigenin-labeled riboprobes
was performed as described (Hari et al., 2002). Mitf- and Dct-specific
riboprobes were used as described (Hari et al., 2002). The 1.2 kb Mitf
riboprobe corresponded to position 177-1399 of the published mouse Mitf
sequence (GenBank accession no. NM_008601) (Bondurand et al., 2000).
lacZ reporter gene expression was detected using X-Gal staining.
Cryosections were fixed for 5 minutes on ice in PBS containing 2%
formaldehyde, 0.2% glutaraldehyde, 0.02% NP40 and stained for 4-16
hours at 37°C in PBS containing 1 mg/ml X-Gal, 10 mM K3Fe(CN)6, 10
mM K4Fe(CN)6, 2 mM MgCl2, 0.02% NP40.
For immunohistochemistry, cryosections were fixed for 5 minutes in 4%
formaldehyde at room temperature and treated with blocking buffer (1%
BSA, 0.3% Triton X-100, in PBS) for 30 minutes. Primary antibodies were
used as follows: mouse anti-Neurog2 (1:10; gift from D. J. Anderson,
California Institute of Technology, Pasadena, CA, USA), goat anti-Dct
(1:200; Santa Cruz sc-10451), mouse anti-Mitf (1:200; Abcam ab12039,
C5 clone), rat anti-c-Kit (1:200; eBioscience 14-1171), mouse anti-PHH3
(1:200; Cell Signaling 9706), goat anti-NeuroD (1:200; Santa Cruz sc-
1084), mouse anti-Cre (1:150; Abcam ab24607), chicken anti--
galactosidase (1:2000; Abcam ab9361), mouse anti-TH (1:200; Sigma
T1299), goat anti-Sox10 (1:200; Santa Cruz sc-17342), rabbit anti-GFP
(1:500; Abcam ab290) and rabbit anti-Brn3a (1:2000; gift from E. E.
Turner, Seattle Children’s Research Institute, Seattle, WA, USA).
Secondary antibodies were from Jackson ImmunoResearch or Invitrogen.
Statistical analysis
All quantifications were performed on 18-m transverse sections.
Recombination efficiency of the Wnt1-Cre line was assessed by counting -
galactosidase/Sox10 double-positive cells among total Sox10-positive cells
in three different Wnt1-Cre/R26R E10.5 embryos at the level of the
hindlimbs, counting five sections per embryo. Recombination efficiency of
Sox10-Cre was quantified by counting Cre/Sox10 double-positive cells
among total Sox10-positive cells in three different Sox10-Cre embryos at the
level of the forelimbs, counting 11 sections per embryo. Fig. 3U represents
the average numbers of Dct-positive cells per MSA at E11.5 and per mm
length of skin at E16.5. At E11.5, Dct-positive cells were counted in 19
MSAs on ten sections per embryo. At E16.5, Dct-positive cells were counted
in the skin of six entire lateral sides (dorsal to ventral) on six sections.
Quantification for both stages was at the level of the forelimbs of three
control and three Sox10-Cre/Ctnnb1ex3 embryos. Proliferation for Fig. 3V
was analyzed by counting PHH3/Sox10 double-positive cells among total
Sox10-positive cells. At E9.5, quantification was performed on every fourth
section between the forelimbs and the hindlimbs; at E10.5, quantification was
on six sections at the level of the forelimbs. Three control and three Sox10-
Cre/Ctnnb1ex3 embryos were quantified for each stage. Brn3a- and Mitf-
positive cells for Fig. 5K were counted on at least seven sections of the
sympathetic ganglia at the level of the forelimbs. Quantifications were
performed on four Wnt1-Cre/Ctnnb1ex3 embryos and on four Sox10-
Cre/Ctnnb1ex3 embryos. Quantification of Mitf- and Brn3a-positive cells
was on adjacent or near-adjacent sections of the same embryos. All results
are shown as mean ± s.d. Statistical analyses (two-tailed unpaired Student’s
t-test; calculation of s.d.) were performed with Microsoft Excel.
RESULTS
-catenin signal activation in premigratory but
not in migratory neural crest cells suppresses
melanocyte specification
Although, in mice, neural crest cells concomitantly engage in the
ventral and dorsolateral migratory pathways (Serbedzija et al.,
1990), neural and melanocyte cell type specification might occur
sequentially. This is reflected by the sequential expression of
transcription factors associated with lineage specification.
Neurogenin 2 (Neurog2), a basic helix-loop-helix (bHLH)
transcription factor required for sensory neurogenesis (Ma et al.,
1996), is already expressed in neural crest cells as they begin to
delaminate from the neural tube (Sommer et al., 1996). By contrast,
the bHLH leucine zipper transcription factor Mitf, which promotes
melanocyte development, is only expressed from E10.5 onwards
(Opdecamp et al., 1997). Accordingly, Neurog2 was prominently
expressed in a subset of migrating neural crest cells and in forming
dorsal root ganglia (DRG) in caudal regions of mouse embryos at
embryonic day (E) 10.5. By contrast, dopachrome tautomerase
(Dct), an enzyme of the pigment synthesis pathway and an early
marker of the melanocyte lineage, was not expressed in these cells
(Fig. 1A). Similarly, at this early stage, neural crest cells marked
by the transcription factor Sox10 (Kuhlbrodt et al., 1998; Paratore
et al., 2001; Kleber et al., 2005) expressed neither Mitf protein,
Mitf mRNA nor c-Kit, another early marker of the melanocyte
lineage (Fig. 1B-D). At E11.5, however, Neurog2 expression was
weak, whereas Mitf was strongly expressed in Sox10-positive cells
found in the MSA (Fig. 1E,F). Expression of Dct, c-Kit and Mitf
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Fig. 1. Sequential expression of sensory and melanocyte markers
in neural crest cells. (A-H) Immunohistochemistry of Neurog2, Dct,
Mitf, Sox10, c-Kit (A-C,E-G) and in situ hybridization analyses of Mitf
expression (D,H) on transverse sections of mouse embryos at E10.5 (A-D)
and E11.5 (E-H). Presumptive neural crest cells next to the caudal neural
tube express the sensory marker Neurog2 at E10.5 (A), whereas they are
still negative for Dct, Mitf protein, c-Kit and Mitf mRNA (A-D,
arrowhead). Dct, Mitf protein, c-Kit and Mitf mRNA are expressed in
migrating neural crest cells only 1 day later in caudal regions at E11.5 (E-
H, arrowhead). Note that Sox10 is expressed in migratory neural crest
cells (B), in the dorsal root ganglia (DRG) (F), as well as in melanoblasts
together with Mitf (F). Insets show single fluorescent channels of the
boxed areas. A-C and E-G show adjacent sections; D and H show
sections of different embryos. NT, neural tube. Scale bar: 50 m. D
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mRNA at this stage further demonstrates that traits of the
melanocyte lineage become apparent after expression of the
sensory lineage marker Neurog2 (Fig. 1A-H).
To address whether the sequential appearance of sensory and
melanocyte lineage markers might involve reiterative -catenin
signaling, we aimed to genetically manipulate -catenin activation
in a temporally controlled manner using the Cre-loxP system. In
Wnt1-Cre transgenic mice, Cre is expressed in the dorsal neural
tube at stages before neural crest delamination (Danielian et al.,
1998; Jiang et al., 2000; Hari et al., 2002). Therefore, Cre
recombinase in these mice is active at least in a subset of the
premigratory neural crest population and its derivatives, as
demonstrated for the stages E8.0 and later by Cre-induced -
galactosidase expression in Wnt1-Cre embryos crossed to the
ROSA26 (R26R) Cre reporter line (Soriano, 1999) (Fig. 2A,C,E,G).
Immunohistochemistry for Cre and Sox10 in Wnt1-Cre mice at
E9.5 confirmed prominent expression of Cre already at
premigratory stages of neural crest development in the dorsal
neural tube, whereas Sox10 was only expressed in Cre-positive
cells after their delamination from the neural tube (Fig. 2I-L).
Importantly, quantification of Cre-dependent -galactosidase
expression in Wnt1-Cre/R26R mice at E10.5 (Fig. 2M-P)
demonstrated that 96±0.4% of all Sox10-expressing migratory
neural crest cells had been subject to Wnt1-Cre-mediated
recombination. Given that Wnt activity drops after neural crest
cells have emigrated from the neural tube (Kleber et al., 2005), our
data indicate that the vast majority of neural crest cells are very
efficiently targeted by Wnt1-Cre activity before, or at the time of,
their emigration from the neural tube.
As in Wnt1-Cre/R26R mice, Cre reporter activity was shown to
occur in all neural crest-derived tissues in Sox10-Cre/R26R animals
(Matsuoka et al., 2005) (Fig. 2D). Unlike Wnt1-Cre, Sox10-Cre
marked neural crest cells only after their emigration from the neural
tube, as shown by staining for Cre reporter-driven -galactosidase
expression both on whole-mount embryos and on transverse
sections at E8.0, E9.5 and E10.5 of Sox10-Cre/R26R embryos (Fig.
2B,D,F,H). Furthermore, Cre protein was detected in 78±1.7% of
all Sox10-positive migratory neural crest cells, but not in the neural
tube of E9.5 Sox10-Cre/R26R embryos (Fig. 2Q-T, arrowhead).
The combined data demonstrate that Wnt1-Cre and Sox10-Cre are
expressed in a large population of lineage-related neural crest cells,
albeit at different stages of their development.
The sequential Cre expression in the neural crest population of
Wnt1-Cre and Sox10-Cre animals allowed us to address a potential
stage-dependent role of canonical Wnt signaling during neural crest
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Fig. 2. Neural crest cells can be manipulated in a temporally
controlled manner using the Cre-loxP system. (A-H) In vivo fate
mapping of neural crest cells by Wnt1-Cre or Sox10-Cre using the Cre
reporter line R26R. X-Gal staining on whole-mounts and on sections
demonstrates recombination in the dorsal neural tube (A,C,E,G,
arrowheads) and in migratory neural crest cells (G, arrow) in Wnt1-
Cre/R26R mouse embryos. By contrast, recombination in Sox10-
Cre/R26R embryos only occurs in migratory neural crest cells (H, arrow),
but never in the neural tube (B,D,F,H, open arrowheads). E and F are
higher magnifications of the boxed areas in C and D, respectively. 
(I-T) Double immunofluorescent staining for Sox10 and either Cre or 
-galactosidase on transverse sections of Wnt1-Cre/R26R and Sox10-
Cre embryos. Cre and -galactosidase are expressed in the dorsal
neural tube and in many Sox10-positive migratory neural crest cells of
E9.5 Wnt1-Cre/R26R embryos (I-L,M-P, arrowheads). By contrast, Cre
protein is detected in the majority of Sox10-positive migratory neural
crest cells but never in the dorsal neural tube of Sox10-Cre embryos 
(T, arrowhead). I-L, M-P and Q-T show overlays and corresponding
single fluorescent channels of the same sections. NT, neural tube. Scale
bars: 500 m in A-D; 50 m in G-T.
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development. Previously, we have demonstrated that expression of
a constitutively active stabilized form of -catenin (Ctnnb1ex) in
the premigratory neural crest of Wnt1-Cre/Ctnnb1ex3 embryos
promotes sensory neurogenesis at the expense of virtually all other
neural crest derivatives, including melanocytes (Lee et al., 2004).
Accordingly, presumptive melanoblasts expressing Mitf or Dct
were absent in the MSA and around the otic vesicle (OV) of Wnt1-
Cre/Ctnnb1ex3 embryos at E11.5 (Fig. 3A-D). By contrast, Mitf-
and Dct-positive cells were present next to the neural tube, in the
MSA, and around the OV of Sox10-Cre/Ctnnb1ex3 embryos at
E11.5 (Fig. 3E-L). Dct-positive cells were able to colonize the skin
and hair follicle primordia of Sox10-Cre/Ctnnb1ex3 embryos at
E16.5 (Fig. 3M,O). The number of recombined cells found in the
hair follicle primordia was comparable in Sox10-
Cre/Ctnnb1ex3/R26R and control embryos (Fig. 3N,P, arrowheads).
Quantification of Dct-positive cells at E11.5 in the MSA and at
E16.5 in the skin further demonstrated the presence of similar
numbers of Dct-positive melanoblasts in Sox10-Cre/Ctnnb1ex3 and
control embryos (Fig. 3U).
These data are in agreement with an earlier study (Delmas et al.,
2007) reporting that constitutive activation of the Wnt/-catenin
pathway in the melanocyte lineage neither increased proliferation
nor the number of melanoblasts. Similarly, proliferation of neural
crest cells was not altered in Sox10-Cre/Ctnnb1ex3 animals, as
demonstrated by quantifying the frequency of mitotic phospho-
histone H3 (PHH3)/Sox10 double-positive cells among neural crest
cells at E9.5 and E10.5 (Fig. 3Q-T,V). Likewise, BrdU
incorporation experiments performed previously in our laboratory
revealed no change in proliferation in cultures of neural crest cells
isolated from Wnt1-Cre/Ctnnb1ex3 embryos (Lee et al., 2004).
Thus, although -catenin signal activation in premigratory neural
crest using the Wnt1-Cre transgenic mouse line prevents formation
of Dct- and Mitf-positive melanoblasts, it does not interfere with
melanocyte lineage specification and localization of appropriate
numbers of Dct-positive cells to the OV and the skin, if activated
after emigration of neural crest cells from the neural tube using the
Sox10-Cre mouse line.
-catenin signal activation in migratory neural
crest cells prevents formation of multiple neural
and non-neural derivatives of the neural crest
The normal generation of orthotopic Dct- and Mitf-positive
melanoblasts in Sox10-Cre/Ctnnb1ex3 embryos raised the question
of whether constitutive -catenin activity affects neural crest cell
fates only at developmental stages of premigratory, but not
migratory, neural crest cells. To address this issue, we further
analyzed the phenotype of Sox10-Cre/Ctnnb1ex3 embryos,
focusing on various neural crest derivatives that fail to properly
form in Wnt1-Cre/Ctnnb1ex3 animals (Lee et al., 2004). In the
head, Sox10-Cre/Ctnnb1ex3 displayed gross morphological
anomalies from E13.5 onwards, with varying degrees of
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Fig. 3. Formation of orthotopic Dct- and Mitf-positive
melanoblasts is not altered in Sox10-Cre/Ctnnb1ex3 embryos. 
(A-P) In situ hybridization analyses on transverse sections of E11.5 and
E16.5 mouse embryos with melanoblast-specific Mitf and Dct
riboprobes and X-Gal staining. Whereas Dct-positive cells are readily
found in the migration staging area (MSA) and around the otic vesicle
(OV) of control embryos, they are absent in Wnt1-Cre/Ctnnb1ex3
embryos (A-D). By contrast, Mitf- and Dct- positive melanoblasts in
Sox10-Cre/Ctnnb1ex3 embryos are found in normal numbers
emigrating from the neural tube in caudal regions (E-H), in the MSA
and OV (I-L) at E11.5, and in the skin and hair follicle primordia at
E16.5 (M-P). X-Gal staining on Sox10-Cre/R26R and Sox10-
Cre/Ctnnb1ex3/R26R embryos shows recombined cells in hair follicle
primordia (N,P, arrowheads). E,F, G,H, M,N and O,P are adjacent
sections. (Q-T) Double immunohistochemistry for Sox10 and phospho-
histone H3 (PHH3) shows comparable numbers of proliferating cells in
Sox10-Cre/Ctnnb1ex3 and control embryos at E9.5 and E10.5.
(U) Quantification of Dct-positive cells per MSA at E11.5 and per mm
skin at E16.5 reveals no significant difference in numbers of Dct-
positive cells between Sox10-Cre/Ctnnb1ex3 and control embryos.
(V) Quantification of PHH3/Sox10 double-positive cells among total
Sox10-expressing cells demonstrates no significant change in
proliferation between Sox10-Cre/Ctnnb1ex3 and control embryos.
mean ± s.d. NT, neural tube; NCC, neural crest cells. Scale bars: 50 m.
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malformations and reduced population of craniofacial structures by
neural crest-derived cells, as shown by in vivo fate mapping at
E14.5 (Fig. 4A-C). Fate mapping experiments using Z/EG reporter
mice (Novak et al., 2000) revealed a strong reduction of peripheral
nerves and of the enteric nervous system in Sox10-
Cre/Ctnnb1ex3/Z/EG embryos (Fig. 4D-I). Furthermore, the
number of autonomic neurons expressing tyrosine hydroxylase
(TH) was drastically reduced in the sympathetic ganglia of Sox10-
Cre/Ctnnb1ex3 animals (Fig. 4J-M). These data demonstrate that
-catenin signaling interferes with the generation of several neural
crest-derived cells types, even if activated only after neural crest
cell emigration.
-catenin signal activation in migratory neural
crest cells leads to the formation of ectopic Mitf-
and Dct-positive melanoblasts and melanocytes
In Wnt1-Cre/Ctnnb1ex3 mice, activation of -catenin signaling
in premigratory neural crest cells results in the generation of
ectopic, often enlarged sensory ganglia (Lee et al., 2004). At
E10.5, such oversized ganglia can be found, for instance, at the
location of normal sympathetic ganglia and contain
undifferentiated Sox10-positive cells, Neurog2-positive sensory
progenitors, and Brn3a-expressing (Pou4f1 – Mouse Genome
Informatics) differentiated sensory neurons (Fig. 5G,H) (Lee et
al., 2004). By contrast, although ectopic Brn3a-positive cells
were still present at the sites of sympathetic ganglia, the ganglia
were smaller in Sox10-Cre/Ctnnb1ex3 than in Wnt1-
Cre/Ctnnb1ex3 embryos (*P<0.05) (Fig. 5G-J). Intriguingly,
whereas in Wnt1-Cre/Ctnnb1ex3 mice only a few Mitf-positive
cells were present at sites where sympathetic ganglia usually
reside, Sox10-Cre/Ctnnb1ex3 embryos exhibited significantly
more Mitf-positive cells in these structures at E10.5 (Fig. 5B-
E,K). The relative number of Brn3a-expressing cells was reduced
accordingly in ganglia of Sox10-Cre/Ctnnb1ex3 embryos (Fig.
5K). Neither Brn3a- nor Mitf-positive cells were detected in
control sympathetic ganglia (Fig. 5A,F). In addition to Mitf, some
of the ectopic cells found in Sox10-Cre/Ctnnb1ex3 embryos
already expressed Dct (data not shown). Double
immunohistochemistry for Mitf and Brn3a, Mitf and NeuroD,
and c-Kit and Brn3a, revealed exclusive expression of ectopic
melanocyte and sensory neuronal markers in Sox10-
Cre/Ctnnb1ex3 embryos at E10.5 (Fig. 5L-W). These
experiments indicate that migratory neural crest cells in Sox10-
Cre/Ctnnb1ex3 embryos undergo proper sensory and melanocyte
lineage formation and lineage segregation, but that a considerable
fraction of these lineages is found at an ectopic site. Moreover,
the concurrent suppression of autonomic neurogenesis and other
neural crest cell lineages in Sox10-Cre/Ctnnb1ex3 embryos (Fig.
4) suggests that -catenin signaling influences neural crest cell
fate decisions after their emigration from the neural tube.
To investigate whether ectopic Dct- and Mitf-positive cells in
Sox10-Cre/Ctnnb1ex3 embryos are restricted to sympathetic
ganglia or more broadly found, we systematically analyzed various
mutant embryo structures for the presence of cells expressing Mitf
and Dct. At E10.5, Mitf-positive cells were found not just within
sympathetic ganglionic anlagen, but also dispersed around these
structures (Fig. 6A,B). At subsequent developmental stages, Dct-
positive cells were detected at several ectopic places in Sox10-
Cre/Ctnnb1ex3 embryos, including in many tissues that usually do
not harbor neural crest derivatives. For instance, at E12.5, the
kidney primordium comprised Dct-expressing cells, which were
shown by in vivo fate mapping to be of neural crest origin (Fig.
5C-F). Additionally, neural crest-derived Dct-positive cells were
detected in the diaphragm, in the spleen and in the urogenital tract
(Fig. 6G-R). Ectopic Dct-positive cells were also found at further
locations, for example in reproductive organs (testes and ovaries)
and around the dorsal aorta (data not shown), and were sometimes
even integrated into epithelial structures. As confirmed by Cre-
mediated genetic cell tracking, all these organs were devoid of
neural crest-derived cells in the control. Of note, many cells
marked by Dct expression or by Cre-induced -galactosidase
expression in different organs of Sox10-Cre/Ctnnb1ex3/R26R
embryos also displayed pigmentation (Fig. 6S-X). Thus, expression
of a constitutively active form of -catenin in migratory neural
crest cells in Sox10-Cre/Ctnnb1ex embryos leads to the ectopic
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Fig. 4. Absence of multiple neural and non-neural derivatives of
the neural crest in Sox10-Cre/Ctnnb1ex3 embryos. (A-C) In vivo
fate mapping of crest-derived craniofacial structures on whole-mount
heads of E14.5 mouse embryos carrying the R26R reporter allele.
Malformations of craniofacial structures in Sox10-Cre/Ctnnb1ex3/R26R
embryos include, most prominently, lack of external ears (arrowheads)
and truncated snouts frequently associated with facial clefts. 
(D-I) Lineage tracing of neural crest derivatives using Z/EG reporter mice
visualized directly by GFP fluorescence (D,E) or with anti-GFP staining
(F-I). Whole-mounts of E14.5 embryos demonstrate reduction of nerves
(arrowheads, enlarged image in insets) and of the enteric nervous
system (arrows) in Sox10-Cre/Ctnnb1ex3/Z/EG embryos (E) as compared
with Sox10-Cre/Z/EG control embryos (D). Absence of the enteric
nervous system of Sox10-Cre/Ctnnb1ex3/Z/EG embryos is confirmed on
transverse sections at E11.5 and E16.5 (F-I). 
(J-M) Immunohistochemistry on transverse sections for the autonomic
neuronal marker tyrosine hydroxylase (TH) reveals a drastic reduction of
autonomic neurons in the sympathetic ganglia of Sox10-Cre/Ctnnb1ex3
embryos. H, head; FL, forelimb; HL, hindlimb. Scale bars: 100 m.
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localization of neural crest-derived Dct- and Mitf-positive
melanoblasts and differentiated bone fide melanocytes in various
embryonic organs.
Ectopic melanoblast formation is due to -catenin
signal activation in migratory neural crest cells
rather than in committed melanoblasts or glial
progenitors
The emergence of extra melanoblasts, concomitant with the loss of
other neural crest derivatives in Sox10-Cre/Ctnnb1ex3 embryos, is
consistent with the idea that -catenin signal activation regulates
cell fate choices in multipotent migratory neural crest cells,
promoting melanoblast formation at the expense of other fates.
Alternatively, -catenin signal activation might cause an expansion
of melanoblasts on their way from the MSA to the skin, leading to
the ectopic localization of excessively produced cells. To exclude
this alternative explanation for the presence of ectopic
melanoblasts, we made use of the inducible Tyr-CreERT2 allele
that drives Cre recombinase in neural crest cells only after
dorsolateral migration and melanocyte fate specification
(Bosenberg et al., 2006) (Fig. 7A). Induction of Ctnnb1ex3
expression by treatment of the pregnant females with tamoxifen at
E11.5 and E12.5 resulted in recombination in melanoblasts in the
skin and in forming hair follicle primordia at E16.5 (Fig. 7C).
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Fig. 5. Formation of ectopic Mitf-positive cells at the location of sympathetic ganglia in Sox10-Cre/Ctnnb1ex3 embryos. (A-J) In situ
hybridization for Mitf and immunohistochemistry for Sox10 and Brn3a on adjacent transverse sections at E10.5. Ectopic Brn3a-positive and ectopic
Mitf-positive cells are detected at the location of the sympathetic ganglia in Wnt1-Cre/Ctnnb1ex3 and in Sox10-Cre/Ctnnb1ex3 but never in control
mouse embryos (A-J). However, the number of ectopic Mitf-positive cells is increased in Sox10-Cre/Ctnnb1ex3 embryos as compared with Wnt1-
Cre/Ctnnb1ex3 embryos (B-E,K). Owing to variations in the phenotype, examples of two different embryos are shown for each genotype.
(K) Percentages of Mitf- and Brn3a-positive cells at the location of the sympathetic ganglia quantified on transverse sections. The relative increase in
Mitf-positive cells among total ectopic cells in Sox10-Cre/Ctnnb1ex3 embryos is statistically significant (*P<0.05) and is accompanied by a relative
decrease in numbers of Brn3a-positive cells. (L-W) Double immunohistochemistry for markers of the melanocyte lineage such as Mitf and c-Kit, and
for markers of the sensory lineage such as Brn3a and NeuroD. Absence of double-positive cells demonstrates that the ectopic cells observed at the
location of the sympathetic ganglia of Sox10-Cre/Ctnnb1ex3 embryos belong to distinct lineages, expressing either sensory or melanocyte markers.
Exclusive expression of Mitf and Brn3a is shown in L,M and R,S, exclusive expression of Mitf and NeuroD is shown in N,O and T,U, and exclusive
expression of c-Kit and Brn3a is depicted in P,Q and V,W. For every double staining, two examples of sympathetic ganglia are shown. L,M, N,O, P,Q,
R,S, T,U and V,W represent the same pictures with and without the DAPI channel for clearer visibility of marker exclusiveness. Scale bars: 50 m.
D
E
V
E
LO
P
M
E
N
T
Consistent with a previous report (Delmas et al., 2007), -catenin
signal activation did not cause an overt increase in melanoblast cell
numbers in the skin of Tyr-CreERT2/Ctnnb1ex3 embryos (data not
shown), disfavoring a role of -catenin signaling in promoting
melanoblast proliferation. Of note, we did not observe any ectopic
melanoblasts in Tyr-CreERT2/Ctnnb1ex3/R26R embryos, as
demonstrated by in vivo fate mapping and in situ hybridization
analysis of Dct expression (Fig. 7D,E, the spleen is shown as an
example). These data are consistent with the idea that ectopic
melanoblasts in Sox10-Cre/Ctnnb1ex3 animals are not a
consequence of increased orthotopic melanoblast proliferation.
Recently, it has been reported that melanocytes not only arise
from neural crest cells migrating along the dorsolateral pathway,
but also from Schwann cell precursors (SCPs) located in nerves
innervating the skin (Adameyko et al., 2009). To address whether
melanocyte fate acquisition at ectopic sites results from elevated -
catenin signaling in nerves, we expressed Ctnnb1ex3 specifically
in peripheral glia by means of Dhh-Cre-mediated recombination
(Jaegle et al., 2003) (Fig. 7A). As previously shown, Dhh-Cre is
active in neural crest-derived cells present along peripheral nerves
(Jaegle et al., 2003; Joseph et al., 2004). In agreement with this,
immunostaining for Cre protein confirmed that Dhh-Cre is not yet
active in migratory neural crest cells at E9.5 (data not shown).
Although recombination in nerves appeared to be efficient in Dhh-
Cre/Ctnnb1ex3/R26R embryos from E12 onwards (Jaegle et al.,
2003) (data not shown), we observed neither recombined
orthotopic melanoblasts (Fig. 7G, arrowhead) nor melanoblasts at
ectopic locations in these animals (Fig. 7H,I; data not shown).
These findings do not support a role of -catenin in promoting the
generation of melanocytes from nerve cells.
Based on fate mapping experiments with an inducible Plp-
CreERT2 line, it has been suggested that the SCP-to-melanocyte
transition occurs within a narrow time window during murine
development at ~E11 (Ernfors, 2010). To exclude the possibility
that Dhh-Cre activity might be too late to track and influence a
SCP-to-melanocyte lineage switch, we induced expression of
Ctnnb1ex3 at various early and late time points using the Plp-
CreERT2 line (Leone et al., 2003). At E9.5, Cre is broadly
expressed in migratory Sox10-positive neural crest cells of Plp-
CreERT2/R26R embryos (Fig. 8B-E). Accordingly, tamoxifen
treatment at this early stage led to Cre-mediated recombination and
-galactosidase expression in the majority of neural crest-derived
cells at E10.5 (Fig. 8F-I) and in multiple neural crest derivatives at
E16.5, such as neuronal cells in the DRG and in the enteric nervous
system, nerves and presumptive melanoblasts in the skin (Fig.
8J,K; data not shown). This indicates that at this early
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Fig. 6. Formation of ectopic melanoblasts at various
locations in Sox10-Cre/Ctnnb1ex3 embryos. Ectopic Dct-
and Mitf-positive melanoblasts are detected by in situ
hybridization on transverse sections using Mitf (A,B) and Dct
(C-V) riboprobes. The neural crest origin of the Dct- and
Mitf-positive melanoblasts is illustrated by anti-GFP or X-Gal
staining using mouse embryos carrying the Z/EG or R26R
reporter lines, respectively. (A-R) The following examples of
organs populated by Dct- and Mitf-positive melanoblasts in
Sox10-Cre/Ctnnb1ex3 embryos are shown: tissue
surrounding the sympathetic ganglia (SG) and the lung buds
(LB) at E10.5 (A,B); the kidney primordium (KP, C-F) at E12.5;
the diaphragm (DI, G-J) at E14.5; the spleen (SP, K-N) at
E16.5; the urogenital tract, around the urethra (U) and the
reproductive ducts (DU, O-R) at E16.5. (S-V) Pigmentation of
Dct-positive ectopic cells in Sox10-Cre/Ctnnb1ex3 embryos
demonstrates their melanocyte identity. Examples of
pigmented cells are shown in the spleen (S), in the ganglion
of Zuckerkandl (ZK, T), around the reproductive ducts (U)
and in the diaphragm (V). (W,X) X-Gal staining shows
recombination in these pigmented melanocytes; cells in the
spleen (W) and around the reproductive ducts (X) are shown
as examples. Note the absence of neural crest-derived cells in
all locations of ectopic Dct-positive cells in control embryos,
as revealed by X-Gal and anti-GFP staining (D,H,L,P). DA,
dorsal aorta; OE, oesophagus; LI, liver; S, stomach. Scale
bars: 100 m in A-R; 50 m in S-X.
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developmental stage, Plp-CreERT2 expression occurs in
unspecified neural crest cells and is not restricted to SCPs. In
agreement with the results obtained with Sox10-Cre/Ctnnb1ex3
animals, -catenin signal activation in Plp-CreERT2/Ctnnb1ex3
embryos at E9.5 led to the appearance of ectopic Dct-positive
melanoblasts at E16.5 (Fig. 8L,M, the spleen is shown as an
example). Cre activity in Plp-CreERT2/Ctnnb1ex3 embryos
became more restricted, however, upon induction at E11.5 and later
stages (Fig. 8N-U). In contrast to Dhh-Cre, Plp-CreERT2
efficiently marked nerves as well as melanoblasts in the skin when
induced at E11.5, E12.5, E14.5, or at postnatal stages (Fig.
8N,O,R,S; data not shown). When activated from E11.5 onwards,
-catenin signaling failed to promote ectopic melanoblast
formation in Plp-CreERT2/Ctnnb1ex3 animals (Fig. 8P,Q,T,U).
These data indicate that -catenin-mediated generation of
melanoblasts at ectopic sites is due to its activation in neural crest
cells before they have localized to nerves or to the skin.
DISCUSSION
Canonical Wnt/-catenin signaling has been shown to play
reiterative roles during neural crest development, sequentially
controlling neural crest induction, neural crest cell delamination,
lineage specification, and differentiation of neural crest derivatives
(Garcia-Castro et al., 2002; Burstyn-Cohen et al., 2004; Lewis et
al., 2004; Kleber and Sommer, 2004; Steventon et al., 2009; Li et
al., 2011). In the present study, we add a new twist to this theme,
demonstrating that the generation of distinct neural crest cell fates
in the mouse is also subject to sequential Wnt/-catenin signaling.
Activation of -catenin in the premigratory neural crest promotes
sensory neurogenesis while suppressing virtually all other possible
lineages, including melanocytes (Lee et al., 2004). If -catenin
signal activation occurs in migratory rather than premigratory
neural crest cells, however, melanocytes represent a major cell type
generated, while most other neural crest cell lineages still fail to
develop. These data suggest that neural crest cell fate decisions are
regulated by stage-dependent differential responsiveness to Wnt/-
catenin signal activation.
Wnt/-catenin signaling regulates sensory and
melanocyte lineage decisions in neural crest cells
Wnt/-catenin signal activation in neural crest cells has previously
been associated either with expansion of pigment cell numbers or
with increased sensory neurogenesis (Dorsky et al., 1998; Jin et al.,
2001; Lee et al., 2004). Differences in the outcomes of these
studies have been attributed, among others, to possible species-
specific mechanisms controlling neural crest lineage decisions
(Sommer, 2011). Our work provides an additional explanation for
how to reconcile the divergent reports: the exact timing of Wnt/-
catenin signal manipulation appears to have an influence on
whether neural crest cells choose to produce sensory neurons or
melanoblasts. The use of mouse lines expressing Cre recombinase
at different stages of neural crest development allowed us to
temporally control conditional Ctnnb1 activation. As demonstrated
by in vivo fate mapping, the use of Wnt1-Cre results in
recombination in the dorsal neural tube at stages when this
structure comprises the premigratory neural crest cell population.
By contrast, Sox10-Cre is not active in premigratory neural crest
cells in the dorsal neural tube. Hence, genetic tracking of Sox10-
Cre-mediated recombination fails to mark cells of the dorsal neural
tube at any developmental stage. However, Sox10-Cre efficiently
labels neural crest cells after their emigration from the neural tube.
As shown by immunostaining for Cre expression and in vivo fate
mapping by means of Cre-mediated -galactosidase expression,
Wnt1-Cre and Sox10-Cre are sequentially active in a large fraction
of lineage-related neural crest cells. Therefore, the differential
outcome of Wnt1-Cre-driven versus Sox10-Cre-driven Ctnnb1
activation is consistent with the idea that canonical Wnt signaling
regulates sensory neurogenesis in neural crest cells before or during
their emigration, when the cells are still localized in or close to the
dorsal neural tube. By contrast, according to this idea, the
melanocyte lineage is promoted after neural crest cell emigration.
This view is also compatible with our previous finding that
conditional inactivation of Ctnnb1 in the premigratory neural crest
reveals a requirement of the Wnt pathway for both sensory neuron
as well as melanocyte formation (Hari et al., 2002).
Although we show that -catenin signal activation is sufficient
to influence neural crest cell lineage decisions in a stage-dependent
manner, we were unable for technical reasons to demonstrate a
stage-dependent requirement for -catenin. Using Cre lines active
in specified melanoblasts and/or in glial progenitors, we have
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Fig. 7. Ectopic melanoblasts are derived from migratory neural
crest cells rather than from melanoblasts or glial progenitors.
(A) Illustration of the different Cre lines used in this study and their
recombination pattern in neural crest cells and their lineage
descendants. (B-I) X-Gal staining on transverse sections of E16.5 mouse
embryos to identify recombined cells carrying the R26R reporter (B-D,F-
H), and in situ hybridization analysis on adjacent sections for Dct to
visualize ectopic melanoblasts (E,I). No ectopic Dct-positive
melanoblasts are formed in Tyr-CreERT2/Ctnnb1ex3/R26R embryos; the
spleen (SP) is shown as an example (D,E). Recombined cells are
detected in hair follicle primordia (C, arrowhead), but not in the in the
dorsal root ganglia (DRG) and nerves (B, arrow). Likewise, the spleen of
Dhh-Cre/Ctnnb1ex3/R26R embryos is devoid of ectopic Dct-positive
melanoblasts (H,I). Recombination is apparent in nerves (F,G, arrows),
but in neither neuronal cells of the DRG nor in melanoblasts in hair
follicle primordia (F,G, arrowhead). NT, neural tube; NCC, neural crest
cells. Scale bars: 100 m in B,D-F,H,I; 50 m in C,G.
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defined a relatively narrow time window during which neural crest
cells respond to -catenin activation by increased melanocyte
formation (see below for further discussion): after neural crest cell
emigration, but before the cells have reached the dorsolateral
migratory pathway or the nerves. Since loss of protein lags behind
conditional gene deletion, Sox10-Cre-dependent ablation of Ctnnb1
did not abolish canonical Wnt signaling during this narrow time
window of signal responsiveness, and neural crest cells were found,
therefore, to adopt a melanocytic fate in Sox10-Cre/Ctnnb1flox/flox
animals (L.H. and L.S., unpublished). However, the combined in
vivo loss- and gain-of-function data, together with the observation
that the Wnt/-catenin pathway is active in a fraction of migratory
neural crest cells in vivo (data not shown), point to a role of
canonical Wnt signaling in controlling melanocyte fate in
migratory neural crest cells after their delamination from the neural
tube.
Wnt/-catenin signaling regulates melanocyte
lineage decisions in migrating neural crest cells
during a narrow time window
The virtual loss of several neural crest derivatives in Sox10-
Cre/Ctnnb1ex3 animals, concomitant with the generation of surplus
melanoblasts in these mice, is consistent with the hypothesis that
migratory neural crest cells can adopt multiple fates in vivo and
that neural crest lineage segregations in these cells can be
influenced after their emigration from the neural tube.
Alternatively, Wnt signaling might induce expansion of committed
melanoblasts, as has been suggested previously based on cell
culture experiments (Dunn et al., 2000). However, constitutive
activation of -catenin in melanoblasts using Tyr-CreERT2-driven
gene expression led neither to cell expansion in the skin,
confirming work by others (Delmas et al., 2007), nor to the
appearance of melanoblasts at ectopic sites. Therefore, altered
proliferation of melanoblasts cannot explain the phenotype
described in the present study.
Apart from dorsolaterally migrating neural crest cells, neural
crest-derived cells along nerves innervating the skin have been
reported to contribute to pigment cell formation (Adameyko et al.,
2009). We used two different Cre-expressing mouse lines to
exclude the possibility that -catenin activation promotes
melanoblast generation from nerve cells rather than from
migratory neural crest cells. In a first mouse line, Cre is expressed
from Dhh promoter elements, which leads to Cre recombinase
activity specifically in nerves from early stages onwards (Jaegle
et al., 2003). Notably, we found no history of recombination in
melanoblasts and melanocytes in these mice, and Dhh-Cre-driven
-catenin activation neither promoted extra melanoblast
generation nor the suppression of other fates. In a second mouse
line, inducible Plp-CreERT2 expression has been used by others
to investigate a transition from SCPs to melanocytes (Leone et al.,
2003; Adameyko et al., 2009). In the present study, we show that
Cre-dependent recombination in these mice marks multiple neural
crest derivatives, including neurons, glia and melanocytes, when
induced at early stages of neural crest development. Induction at
later stages revealed a more restricted expression pattern of Cre,
with recombination being detectable in both glia and melanocytes
at all stages examined, including postnatally. Given the reported
SCP-melanocyte transition observed in Plp-CreERT2 mice, it is
unclear why Dhh-Cre-mediated recombination does not label
melanoblasts. Possibly, some melanocytic cells are marked
independently of glia in Plp-CreERT2 animals. Alternatively,
Dhh-Cre and Plp-CreERT2 might be expressed in distinct nerve
cell subpopulations (Sommer, 2011). In any case, the dynamic
activity of Plp-CreERT2 during development allowed us to
confirm that ectopic melanoblasts found in Sox10-Cre/Ctnnb1ex3
animals are due neither to enhanced SCP-to-melanoblast
transition nor to expansion of melanoblasts: surplus melanoblasts
were only seen in Plp-CreERT2/Ctnnb1ex3 when Cre
recombinase was induced at early stages to mark multiple neural
crest derivatives, but not when recombination in these mice was
restricted to nerve cells and melanocytes at stages E11.5 or later.
These data demonstrate that -catenin activation can promote the
generation of melanoblasts only during a narrow time window of
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Fig. 8. Formation of ectopic melanoblasts in Plp-CreERT2/
Ctnnb1ex3 embryos is induced only during a narrow time
window. (A) Illustration of recombination patterns obtained by Plp-
CreERT2-mediated Cre activation. (B-I) Double immunohistochemistry
for Sox10 and either Cre or -galactosidase on transverse sections of
Plp-CreERT2/R26R mouse embryos. At E9.5, Cre is expressed in many
migratory Sox10-positive neural crest cells of Plp-CreERT2/R26R
embryos (B-E). Consequently, tamoxifen (TM) treatment at this early
stage results in Cre-mediated recombination and -galactosidase
expression in the majority of neural crest-derived cells at E10.5 (F-I). B-E
and F-I are overlays and corresponding single fluorescent channels of
the same sections. (J-U) Expression of stabilized -catenin in Plp-
CreERT2/Ctnnb1ex3/R26R induced at different developmental stages.
Activation of Plp-CreERT2 by injection of tamoxifen at E9.5 results in
efficient recombination of cells in the DRG, nerves (J,K, arrows) and of
melanoblasts localized to forming hair follicles (K, arrowhead).
Numerous ectopic X-Gal-stained and Dct-positive melanoblasts are
found in the spleen (L,M) and in other organs. Activation of Plp-
CreERT2 at E11.5 and at E14.5 results in staining of nerves (N,R,
arrows) and of melanoblasts (O,S, arrowheads). The spleen of these
embryos is devoid of ectopic Dct-positive or X-Gal-stained melanoblasts
(P,Q,T,U). NT, neural tube; NCC, neural crest cells. Scale bars: 100 m
in J,L-N,P-R,T,U; 50 m in B-I,K,O,S.
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neural crest development, after emigration of neural crest cells
and before their association with nerves or engagement in the
dorsolateral pathway.
The proposed relatively narrow time window of -catenin
responsiveness in migratory neural crest cells might also explain why
surplus melanoblasts are found at ectopic sites within the embryo,
rather than at their normal location in the skin. Normally, neural crest
cells destined for a melanocytic fate localize to the MSA and then
migrate dorsolaterally to populate the skin. Conceivably, -catenin
activation in Sox10-Cre/Ctnnb1ex3 embryos imposes a melanocytic
fate on neural crest cells before they have reached their destination
in the skin. This causes ventrally migrating neural crest cells to
generate melanoblasts at the expense of other derivatives.
Intriguingly, in Sox10-Cre/Ctnnb1ex3 mice, ectopic melanoblasts and
melanocytes are not only found in neural crest target structures, such
as the autonomic ganglia, but also in tissues that are normally devoid
of neural crest derivatives, such as the spleen, urogenital tract and
diaphragm. Although this needs to be addressed, the extensive
migration of -catenin-overexpressing melanocytic cells might
reflect processes that are also relevant to the high migratory capacity
of cells present in aggressive melanoma.
Multipotency and lineage restrictions in avian and
mouse neural crest cells
Earlier clonal assays in avian embryos indicated that at least some
neural crest cells are multipotent in vivo, generating clones
composed of both pigment and neural cell types (Bronner-Fraser
and Fraser, 1988; Bronner-Fraser and Fraser, 1989; Frank and
Sanes, 1991). A more recent study suggested, however, that neural
crest cells are already lineage restricted prior to their emigration
from the neural tube: at early stages, cells migrate ventrally to form
neural structures only, whereas at later stages cells migrate
dorsolaterally to exclusively produce melanocytes (Krispin et al.,
2010a; Krispin et al., 2010b). According to these data, multifated
neural crest cells (i.e. cells adopting multiple fates) would be rare
in avian embryos, and the majority of neural crest cells would
consist of discrete cell subpopulations generating single rather than
multiple cell types (Krispin et al., 2010b). In contrast to avian
embryos, there is no evidence for a temporal switch from ventral
to dorsolateral migration in mouse embryos, as mouse neural crest
cells migrate dorsolaterally at the onset of neural crest migration
(Serbedzija et al., 1990). In addition, single-cell labeling in mouse
embryos identified many clones composed of multiple neural crest
derivatives, including neural cells and presumptive melanocytic
cells in the dorsolateral pathway (Serbedzija et al., 1994).
Despite these data, our findings support the idea that the
generation of distinct neural crest lineages in the mouse is also
subject to temporal control mechanisms, as in avian embryos.
Because most, but not all, neural crest cells are targeted by Cre in
the mouse lines used in this study, we cannot exclude a certain
heterogeneity in the neural crest cell population with respect to
Wnt/-catenin responsiveness at a given time point. Nonetheless,
a large fraction of neural crest cells appears to be multipotent rather
than lineage determined at premigratory as well as migratory
stages, and their fate can be influenced in vivo by modulation of
cues controlling lineage choices. However, our findings do not
exclude the possibility that cells with the potential to respond to -
catenin signaling and to adopt multiple fates upon signal
manipulation might actually be lineage restricted during normal
development. Thus, whether multipotent cells are also multifated
at different stages of neural crest development in vivo needs to be
elucidated in future studies.
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